Literature DB >> 9046195

Nasosinusal fungal granuloma--clinical profile.

G Andrews1, M Kurien, V Anandi, B Ramakrishna, R Raman.   

Abstract

Fifty cases of nasosinusal fungal granuloma were admitted under the ENT Department in a teaching tertiary care hospital in India during a thirteen-year period. Aspergillus species was found to be the most common causative fungus (29) followed by Mucorales (14), Entomophthorales (5) and Fusarium (2) species. There were 13 cases of non-invasive and 16 cases of invasive variants of Aspergillosis. In spite of intravenous amphotericin B therapy and radical surgical debridement, 81% in the invasive group showed relapse and required prolonged oral antifungal drugs and multiple surgical procedures. Among the 14 cases of Mucormycosis, all of the 10 cases who received intravenous amphotericin B and radical surgery showed complete recovery with no relapse over a period of 2 to 10 years. This is contrary to earlier published reports which suggest poor prognosis. The entomophthoromycosis received oral steroids and cotrimoxazole, and oral potassium iodide or intravenous amphotericin in case of relapse. Both the cases of Fusariosis recovered completely with oral ketoconazole.

Entities:  

Mesh:

Year:  1996        PMID: 9046195

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  3 in total

1.  Evidence implicating Thamnostylum lucknowense as an etiological agent of rhino-orbital mucormycosis.

Authors:  Immaculata Xess; Sarita Mohapatra; M R Shivaprakash; Arunaloke Chakrabarti; Gerald L Benny; Kerry O'Donnell; Arvind A Padhye
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

2.  Orbital proptosis in a young immunocompetent female patient.

Authors:  Partha Roy; S Chanda; S C Gupta; A K Aggarwal
Journal:  Med J Armed Forces India       Date:  2014-08-04

3.  Chronic rhinofacial mucormycosis caused by Mucor irregularis (Rhizomucor variabilis) in India.

Authors:  B M Hemashettar; R N Patil; Kerry O'Donnell; Vishnu Chaturvedi; Ping Ren; Arvind A Padhye
Journal:  J Clin Microbiol       Date:  2011-04-20       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.